Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


29.01.2024

1 Am Heart J
3 Am J Cardiol
3 Circ Heart Fail
2 Circ Res
1 Circulation
2 Clin Cardiol
1 Eur Heart J
14 Eur J Heart Fail
6 Int J Cardiol
1 J Am Coll Cardiol
2 J Card Fail


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available


    Am J Cardiol

  2. CELIK A, Sahin A, Ata N, Colluoglu IT, et al
    Navigating Heart Failure: Unveiling Sex Disparities in Guideline-Directed Medical Therapy Combinations.
    Am J Cardiol. 2024 Jan 22:S0002-9149(24)00063.
    PubMed         Abstract available

  3. YONG JH, Mai AS, Matetic A, Elbadawi A, et al
    Cardiovascular Risk in Patients with Haematological Malignancies: A Systematic Review and Meta-Analysis of 1,960,144 cases.
    Am J Cardiol. 2023 Nov 30:S0002-9149(23)01331.
    PubMed         Abstract available

  4. SKEETE J, Huang HD, Mazur A, Sharma PS, et al
    Evolving Concepts in Cardiac Physiologic Pacing in the Era of Conduction System Pacing.
    Am J Cardiol. 2024;212:51-66.
    PubMed         Abstract available


    Circ Heart Fail

  5. CLAUDEL SE, Powell-Wiley TM
    Outcomes Associated With Surgical and Pharmacologic Treatment of Obesity in Heart Failure.
    Circ Heart Fail. 2024 Jan 26:e011323. doi: 10.1161/CIRCHEARTFAILURE.123.011323.
    PubMed        

  6. MENTIAS A, Desai MY, Aminian A, Patel KV, et al
    Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity.
    Circ Heart Fail. 2024 Jan 26:e010453. doi: 10.1161/CIRCHEARTFAILURE.122.010453.
    PubMed         Abstract available

  7. HARRINGTON J, Mentz RJ, Rockhold FW, Garg J, et al
    Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial.
    Circ Heart Fail. 2024 Jan 22:e010676. doi: 10.1161/CIRCHEARTFAILURE.123.010676.
    PubMed         Abstract available


    Circ Res

  8. WANG YC, Koay YC, Pan C, Zhou Z, et al
    Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2024 Jan 24. doi: 10.1161/CIRCRESAHA.123.322381.
    PubMed         Abstract available

  9. SERIO S, Pagiatakis C, Musolino E, Felicetta A, et al
    Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis.
    Circ Res. 2023;133:687-703.
    PubMed         Abstract available


    Circulation

  10. SUMARSONO A, Xie L, Keshvani N, Zhang C, et al
    Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Circulation. 2024 Jan 23. doi: 10.1161/CIRCULATIONAHA.123.067489.
    PubMed         Abstract available


    Clin Cardiol

  11. SAWAN MA, Prabakaran S, D'Souza M, Behbahani-Nejad O, et al
    A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
    Clin Cardiol. 2024;47:e24207.
    PubMed         Abstract available

  12. TSAI TH, Tsai ML, Chen DY, Lin Y, et al
    Evaluating the applicability of ivabradine in acute heart failure.
    Clin Cardiol. 2024;47:e24206.
    PubMed         Abstract available


    Eur Heart J

  13. BERNARDO MC, Carvalho SS, Moreira I
    Massive myocardial calcification as an aetiology of heart failure.
    Eur Heart J. 2024 Jan 23:ehae009. doi: 10.1093.
    PubMed        


    Eur J Heart Fail

  14. DE FILIPPO O, Cammann VL, Pancotti C, Di Vece D, et al
    Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model.
    Eur J Heart Fail. 2023;25:2299-2311.
    PubMed         Abstract available

  15. KOURANOS V, Khattar RS, Okafor J, Ahmed R, et al
    Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
    Eur J Heart Fail. 2023;25:2287-2298.
    PubMed         Abstract available

  16. MARTYN T, Saef J, Khot UN, Martinez KA, et al
    The utilization and impact of cardiovascular specialists on guideline-directed medical scores: An analysis of a diverse, multi-state, electronic health record-based registry.
    Eur J Heart Fail. 2023;25:2333-2336.
    PubMed        

  17. POLOVINA M, Tschope C, Rosano G, Metra M, et al
    Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.
    Eur J Heart Fail. 2023;25:2144-2163.
    PubMed         Abstract available

  18. RUSSO G, Badano LP, Adamo M, Alessandrini H, et al
    Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry.
    Eur J Heart Fail. 2023;25:2243-2251.
    PubMed         Abstract available

  19. DELMAS C, Vandenbriele C, Pappalardo F, Roubille F, et al
    What about current recommendations for extracorporeal life support in acute myocardial infarction-associated cardiogenic shock: Stay or go? or time to revise?
    Eur J Heart Fail. 2023;25:2102-2104.
    PubMed        

  20. CANNATA A, Bromage DI, McDonagh TA
    When observation meets randomization: 'Don't let a crisis go to waste'.
    Eur J Heart Fail. 2023;25:2189-2190.
    PubMed        

  21. D'AMARIO D, Borovac JA, Patti G
    A machine-learning-based prediction model in patients with takotsubo syndrome: 'You can't stop change any more than you can stop the suns from setting!'.
    Eur J Heart Fail. 2023;25:2312-2315.
    PubMed        

  22. DAUW J, Meekers E, Martens P, Deferm S, et al
    Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling.
    Eur J Heart Fail. 2024 Jan 21. doi: 10.1002/ejhf.3131.
    PubMed         Abstract available

  23. GONZALEZ-DEL-HOYO M, Rossello X
    Worsening heart failure comes into focus, chronic heart failure takes a backseat.
    Eur J Heart Fail. 2024 Jan 21. doi: 10.1002/ejhf.3143.
    PubMed        

  24. ABDIN A, Lauder L, Fudim M, Abraham WT, et al
    Neuromodulation interventions in the management of heart failure.
    Eur J Heart Fail. 2024 Jan 21. doi: 10.1002/ejhf.3147.
    PubMed         Abstract available

  25. TOMASONI D, Adamo M, Metra M
    December 2023 at a glance: Focus on medical therapy in chronic and acute heart failure.
    Eur J Heart Fail. 2023;25:2099-2101.
    PubMed        

  26. MULLENS W, Dauw J, Gustafsson F, Mebazaa A, et al
    Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
    Eur J Heart Fail. 2024 Jan 25. doi: 10.1002/ejhf.3150.
    PubMed         Abstract available

  27. HULLIN R
    Advantage of uptitration of foundational heart failure drugs in heart failure with reduced ejection fraction and low blood pressure.
    Eur J Heart Fail. 2024 Jan 25. doi: 10.1002/ejhf.3144.
    PubMed        


    Int J Cardiol

  28. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    PubMed         Abstract available

  29. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
    Impaired retinal micro-vascular function in patients with atrial fibrillation.
    Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
    PubMed         Abstract available

  30. MORONI F, Corna G, Del Buono MG, Golino M, et al
    Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
    PubMed         Abstract available

  31. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    PubMed         Abstract available

  32. KANG DW, Kang SH, Lee K, Nam K, et al
    Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.
    Int J Cardiol. 2024 Jan 17:131786. doi: 10.1016/j.ijcard.2024.131786.
    PubMed         Abstract available

  33. YAMAGUCHI N, Hirata Y, Nishio S, Takahashi T, et al
    Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor.
    Int J Cardiol. 2024 Jan 20:131789. doi: 10.1016/j.ijcard.2024.131789.
    PubMed         Abstract available


    J Am Coll Cardiol

  34. CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al
    Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:488-499.
    PubMed         Abstract available


    J Card Fail

  35. SOLOVEVA A, Fedorova D, Fudim M, Vinogradova N, et al
    Blood pressure response and symptoms during active standing test among hospitalized and outpatients with heart failure: results from the GRAVITY-HF prospective observational cohort study.
    J Card Fail. 2024 Jan 17:S1071-9164(24)00013.
    PubMed         Abstract available

  36. BISOL RV, Clausell N, Vieira JL, Bacal F, et al
    Advanced Heart Failure and Transplant Cardiology as a New Subspecialty in Latin America: Challenges and Opportunities Based on a Brazilian Survey Study.
    J Card Fail. 2024 Jan 22:S1071-9164(24)00011.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.